INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.;CHUGAI SEIYAKU KABUSHIKI KAISHA; INC.;INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY;DAINIPPON SUMITOMO PHARMA CO., LTD.
发明人:
NISHIHARA, TOSHIO,GOTOH, MASASHI
申请号：
CA2631292
公开号：
CA2631292C
申请日:
2006.11.29
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
Cancer vaccines offer potential for cancer prophylaxis and therapy. Disclosedherein are derivatives of cancer antigen peptides derived from WT1, which havecytotoxic T-Iymphocyte induction activity in vivo, and which are useful ascancervaccines.
